Abstract Metabolic co-regulation between biosynthetic pathways for secondary metabolites is common in microbes and can play an important role in microbial interactions. Here, we describe a novel mechanism of metabolic co-regulation in which an intermediate in one pathway is converted into signals that activate a second pathway. Our study focused on the co-regulation of 2,4-diacetylphloroglucinol (DAPG) and pyoluteorin, two antimicrobial metabolites produced by the soil bacterium Pseudomonas protegens. We show that an intermediate in DAPG biosynthesis, phloroglucinol, is transformed by a halogenase encoded in the pyoluteorin gene cluster into monoand di-chlorinated phloroglucinols. The chlorinated phloroglucinols function as intra-and intercellular signals that induce the expression of pyoluteorin biosynthetic genes, pyoluteorin production, and pyoluteorin-mediated inhibition of the plant-pathogenic bacterium Erwinia amylovora. This metabolic co-regulation provides a strategy for P. protegens to optimize the deployment of secondary metabolites with distinct roles in cooperative and competitive microbial interactions.
Introduction
Many microorganisms produce multiple secondary metabolites with diverse chemical properties and ecological functions that contribute to the fitness of the producing organism in natural environments (Haas and Keel, 2003; O'Brien and Wright 2011, Traxler and Kolter, 2015) . The biosynthesis of different secondary metabolites by a microorganism is often coordinated (Bosello et al., 2011; Tsunematsu et al., 2013; Hidalgo et al., 2014; Vingadassalon et al., 2015; Cano-Prieto et al., 2015; Cui et al., 2016) . Co-regulation of different secondary metabolites is thought to be selected during microbial evolution because it confers competitive advantages to the producing organism in microbial interactions (Challis and Hopwood, 2003) .
Among the secondary metabolites, antibiotics are particularly intriguing because of their roles in both cooperative and competitive interactions among microorganisms in natural habitats (Yim et al., 2007; Raaijmakers and Mazzola, 2012) . This study focuses on 2,4-diacetylphloroglucinol (DAPG) and pyoluteorin, two broad-spectrum antibiotics with toxicity against fungi, bacteria, oomycetes and plants (Ohmori et al., 1978; Keel et al., 1992) . Certain strains of Pseudomonas spp. produce DAPG but not pyoluteorin (Loper et al., 2012) and some strains of Pseudomonas aeruginosa produce pyoluteorin but not DAPG (Ohmori et al., 1978) . To date, only a subset of strains of the species Pseudomonas protegens are known to produce both compounds (Loper et al., 2012) . Among these DAPG-and pyoluteorin-producing strains is the soil bacterium P. protegens Pf-5. In the genome of Pf-5, genes for DAPG and pyoluteorin biosynthesis are present in two different gene clusters ( Figure 1A and C) separated by 3.7-megabases (Paulsen et al., 2005) . The biosynthetic substrates and intermediates of the two pathways are distinct (Figure 1B and D) . DAPG biosynthesis begins with synthesis of phloroglucinol (PG) from three molecules of malonyl-CoA by the type III polyketide synthase PhlD (Achkar et al., 2005) . PG is then acetylated through the action of PhlABC to form DAPG (Bangera and Thomashow, 1999) . Pyoluteorin biosynthesis begins with activation of L-proline by the L-prolyl-AMP ligase PltF, and attachment to the peptidyl-carrier protein PltL (Thomas et al., 2002) . The Pro-S-PltL intermediate is oxidized by PltE and chlorinated by PltA to yield 4,5-dichloropyrrolyl-S-PltL (Thomas et al., 2002; Dorrestein et al., 2005) . The dichloropyrrole is extended by the type I polyketide synthase PltBC followed by release and formation of the resorcinol, presumably catalyzed by PltG to yield pyoluteorin (Nowak-Thompson et al., 1997 .
Despite the independent biochemical and genetic determinants for their biosynthesis, production of DAPG and pyoluteorin by P. protegens is tightly coordinated. Mutations in pyoluteorin biosynthetic genes result in loss of pyoluteorin production along with overproduction of DAPG (Brodhagen et al., 2004; Quecine et al., 2016) , and addition of pyoluteorin to bacterial cultures represses the expression of certain DAPG biosynthetic genes and the production of DAPG Baehler et al., 2005) . Conversely, PG, an intermediate in DAPG biosynthesis, has a concentration-dependent influence on expression of pyoluteorin biosynthetic genes and production of pyoluteorin: nanomolar concentrations of PG are required for pyoluteorin eLife digest Bacteria live almost everywhere on Earth and often compete with one another for limited resources, like space or nutrients. Certain bacteria produce molecules that are toxic to other microorganisms to give themselves a competitive advantage. These toxic molecules are more commonly referred as antibiotics, and are perhaps best known for their importance in medicine. Yet, antibiotics benefit the bacteria that produce them in other ways too. Some bacteria, for example, use antibiotics as chemical signals to communicate with one another and coordinate their activities.
Some bacteria produce many antibiotics with different toxic and signaling activities. These bacteria often coordinate the production of different antibiotics such that the production of one antibiotic shuts down the production of another. This kind of coordination would allow the bacterium to focus its energy on producing only the antibiotic that gives it a competitive advantage at that time. Yet, in most cases, it was not known how the bacterial cell coordinates the production of two different antibiotics.
Pseudomonas protegens is a species of bacteria that lives in soil, and produces many antibiotics that are toxic to other bacteria or fungi. The antibiotics are made via distinct pathways of chemical reactions that are catalyzed by different enzymes. However, the production of two antibiotics, called 2,4-diacetylphloroglucinol and pyoluteorin, is tightly coordinated in some strains of P. protegens. Now, Yan et al. have discovered how P. protegens coordinates the production of these two antibiotics. It turns out that the bacterium produces an enzyme that adds chlorine atoms onto one of the intermediate building blocks used to make 2,4-diacetylphloroglucinol. These "chlorinated derivatives" then activate the genes required to make the second antibiotic, pyoluteorin. The derivatives also signal to other P. protegens cells and trigger them to produce pyoluteorin too. Lastly, Yan et al. confirmed that pyoluteorin could inhibit the growth of another species of bacteria called Erwinia amylovora.
These new findings highlight an important role played by chemicals that might have previously been considered as merely stepping stones in other biochemical reactions. An important challenge for the future will be to evaluate if other microbes use chemical intermediates in similar ways. Understanding the natural role of more antibiotics and their intermediates should help us to more wisely use existing antibiotics, and might eventually lead to new treatments for infections in humans and other animals.
production but micromolar concentrations of PG repress pyoluteorin production (Kidarsa et al., 2011; Clifford et al., 2016) .
The essential role of PG in pyoluteorin production became evident when we discovered that a phlD mutant, which lacks the type III polyketide synthase PhlD responsible for PG biosynthesis, produces neither pyoluteorin nor DAPG. The phlD mutant can be complemented for pyoluteorin production by addition of nanomolar concentrations of PG to the culture medium (Kidarsa et al., 2011) . Furthermore, addition of nanomolar concentrations of PG induces expression of pyoluteorin biosynthetic genes (Clifford et al., 2016) , indicating that the influence of PG on pyoluteorin production is mediated through gene regulation. Pyoluteorin itself also induces expression of pyoluteorin biosynthetic genes (Brodhagen et al., 2004; Li et al., 2012) . The pyoluteorin biosynthetic genes are expressed under the positive control of PltR (Brodhagen et al., 2004) (Figure 1) , a transcriptional regulator belonging to the LysR family. Both PG and pyoluteorin are known to induce PltR-mediated transcription of pyoluteorin biosynthetic genes, but the relative importance of the two small molecules in inducing gene expression has not been evaluated. The metabolic co-regulation between DAPG and PLT biosynthetic pathways differs from known examples of metabolic co-regulation between secondary metabolic pathways, which can be classified into four types based on the underlying mechanisms. The first type of co-regulation involves one or more intermediates that are shared by different biosynthetic pathways (Vingadassalon et al., 2015; Cano-Prieto et al., 2015) . The second type results when a single enzyme is shared by different pathways (Lazos et al., 2010; Tsunematsu et al., 2013) . The third type of co-regulation is mediated through functionally redundant enzymes present in different pathways (Lautru et al., 2007) . The fourth type occurs when the biosynthetic genes for two pathways are controlled by the same 'pathway-specific' regulator (Pérez-Llarena et al., 1997; Bergmann et al., 2010) . Overall these mechanisms of metabolic co-regulation involve a shared biosynthetic intermediate, enzymatic activity, or regulator, but none of these features is shared by the DAPG and pyoluteorin pathways (Figure 1) .
Here, we describe a mechanism of metabolic co-regulation that is distinct from all described previously. Our results show that PG, an intermediate in DAPG biosynthesis, is transformed by a halogenase encoded in the pyoluteorin gene cluster into chlorinated derivatives that function as cell-cell communication signals inducing expression of pyoluteorin biosynthetic genes. Our work reveals a new mechanism of co-regulation between two secondary metabolic pathways, which is mediated by an intermediate in one pathway that is converted into signals that activate the second pathway.
Results

PG is required for PltR-mediated activation of pltL expression
To determine the differences between the regulatory roles of PG and pyoluteorin in the production of pyoluteorin, we evaluated the effects of both metabolites on expression of the pyoluteorin biosynthetic gene pltL using pL-gfp ( Figure 1E ), a reporter construct containing a transcriptional fusion of the promoter of pltL to a promoterless gfp (Yan et al., 2016) . GFP expressed from pL-gfp was monitored in a DpltADphlD double mutant grown in a medium amended with each of the two metabolites alone or in combination (Figure 2 ). In the non-amended medium, and relative to wildtype Pf-5, GFP expression was significantly lower in the DpltADphlD mutant (p=2.76E-4), indicating only background expression of pltL. This result was expected because of the deletion of pltA and phlD, which encode enzymes for biosynthesis of pyoluteorin and PG, respectively ( Figure 1) ; both pyoluteorin and PG are known to induce expression of pyoluteorin biosynthetic genes (Brodhagen et al., 2004; Clifford et al., 2016) . In the medium amended with 10 nM PG, GFP expression of the DpltADphlD mutant increased nearly tenfold relative to expression levels in nonamended medium, indicating induction of pltL. In contrast, addition of 100 nM pyoluteorin failed to alter GFP expression by the DpltADphlD mutant. However, when both pyoluteorin and PG were added, the GFP expression was significantly higher than under treatment with PG alone (p=1.44E-4). Therefore, pyoluteorin was not required for pltL expression but further induced pltL expression in the presence of PG. As expected based on the necessity of PltR for expression of the pyoluteorin biosynthetic genes (Brodhagen et al., 2004; Li et al., 2012) , pltR was required for expression of pltL and the presence of PG could not restore pltL expression in a DpltADphlDDpltR mutant (Figure 2) . These results indicated that PG, not pyoluteorin, is required for PltR-mediated activation of pltL.
PG activates expression of pltL indirectly
To test whether PG directly or indirectly regulates expression of the pyoluteorin biosynthetic genes, we assessed the effect of PG on expression of pltL in P. fluorescens SBW25. Like P. protegens Pf-5, strain SBW25 is a member of the P. fluorescens group but, unlike Pf-5, SBW25 has neither the phl gene cluster nor the plt gene cluster (Silby et al., 2009) . Because SBW25 does not have pltR, which is required for pltL expression, we made the transcriptional reporter construct pRL-gfp, which contains pltR and the intergenic region between pltR and pltL that includes the promoter of pltL fused to a promoterless gfp ( Figure 1F ). Although PG was sufficient to induce pltL expression in Pf-5 (Figure 2) , PG failed to induce GFP expression from pRL-gfp in P. fluorescens SBW25 ( Figure 3A) and is therefore not likely to function as a signal directly. One possible explanation for these results is that Pf-5 processes PG to another compound, which then directly induces pyoluteorin gene expression.
To test this possibility, we amended SBW25 carrying pRL-gfp with culture supernatants from Pf-5 or the DphlD mutant and measured pltL expression. Consistent with our hypothesis, culture supernatants from Pf-5, but not the DphlD mutant, could induce GFP expression of SBW25 ( Figure 3A) . Therefore, we concluded that PG does not directly influence pyoluteorin gene expression. Rather, PG could be converted to a compound(s) that regulates pyoluteorin gene expression. pltM is necessary and sufficient for the PltR-mediated activation of pltL expression by PG We then attempted to identify a mechanism by which Pf-5 could convert PG to the compound(s) that directly induces pyoluteorin gene expression. Within the plt gene cluster of Pf-5, pltM attracted our attention because of its proximity to pltR ( Figure 1C ). pltM and pltR are predicted to form a bicistronic operon because of a four-base overlap between the 5' end of pltM and the 3' terminus of pltR (Paulsen et al., 2005) . Moreover, pltM and pltR share similar transcriptional profiles, which differ from those of other genes in the plt gene cluster (Figure 3-figure supplement 1 ; Clifford et al., 2016) . PltM is a putative FADH 2 -dependent halogenase and is required for pyoluteorin production: a pltM insertion mutant is deficient in the production of pyoluteorin (NowakThompson et al., 1999) . The reason why PltM is required is unclear because the plt gene cluster encodes another FADH 2 -dependent halogenase PltA that catalyzes the addition of both chlorines to the pyrrole moiety to form pyoluteorin (Dorrestein et al., 2005) . Therefore, we hypothesized that PltM is responsible for conversion of PG into the compound(s) that induces the expression of pyoluteorin biosynthetic genes.
To avoid any concerns regarding potential polar effects of the insertion in the previously derived pltM mutant (Nowak- Thompson et al., 1999) , we generated a mutant with an in-frame deletion of pltM and confirmed that the DpltM mutant does not produce pyoluteorin ( Figure 3 -figure supplement 2). Pyoluteorin production by the DpltM mutant could be complemented by a plasmid-borne copy of pltM, confirming that pltM has an essential role in pyoluteorin production.
We introduced pL-gfp into the DpltM mutant and found that the mutant expressed only background levels of GFP, indicating that expression of pltL was not induced in this mutant ( Figure 3B ). The GFP expression remained at background levels even when cells were grown in the presence of 10 nM PG. However, GFP expression of the DpltM mutant was induced by culture supernatants of Pf-5 ( Figure 3B ). As expected, culture supernatants of the DphlD mutant failed to induce GFP expression of the DpltM mutant containing pL-gfp. These results supported our hypothesis and indicated that wild-type Pf-5, but not the DpltM mutant, produces the compound(s) that induces the pltL expression.
To test whether pltM is sufficient for signaling in SBW25, we made a transcriptional fusion construct pMRL-gfp, which contains pltM, pltR, and the intergenic region between pltR and pltL that includes the promoter of pltL fused with the promoterless gfp ( Figure 1G ). Like SBW25 containing pRL-gfp, SBW25 containing pMRL-gfp had only low, background GFP expression in the nonamended medium, and higher GFP expression level in the presence of culture-supernatants from wild-type Pf-5 ( Figure 3A and C). While PG failed to induce GFP expression of SBW25 containing pRL-gfp ( Figure 3A) , it induced GFP expression of SBW25 containing pMRL-gfp ( Figure 3C ). These results indicated that pltM is sufficient for signaling in SBW25 in the presence of PG and the regulatory gene pltR.
Identification of chlorinated phloroglucinols from Pf-5 cultures
To identify the compound(s) that induce(s) expression of pltL, we extracted bacterial metabolites from cultures of the wild-type Pf-5 and the DpltM mutant, and analyzed the extracts by liquid chromatography-mass spectrometry (LCMS). This analysis revealed the presence of 2-chlorobenzene-1,3,5-triol (PG-Cl) in culture extracts of the wild-type Pf-5 but not the DpltM mutant . We also separated the extracts of the wild-type into fractions using semi-preparatory HPLC, and assayed the fractions for signaling activity. This analysis revealed two peaks that induced pltL expression in SBW25 (pPL-gfp) ( Figure 4C ), suggesting that Pf-5 produces at least two signaling compounds.
To obtain sufficient levels of signaling molecules for chemical analysis, we constructed a derivative strain of Pf-5 that overproduced the signaling compounds. This overproducing strain is a DgacA mutant of Pf-5 carrying plasmid pME6010-pltM, which expresses pltM from a constitutive . Identification of the signaling metabolites from Pf-5 that induce expression of pltL::gfp in P. fluorescens SBW25 (pRL-gfp). Metabolites were extracted from wild-type (WT) Pf-5, and a phloroglucinol (PG)-fed DgacA mutant of Pf-5 carrying a plasmid that constitutively expresses pltM (pME6010-pltM). The extracts were fractioned into 48 fractions using semi-preparatory HPLC (no observable signal activity was detected from the last 12 fractions, data not shown). The signal activity of the fractions from both strains was tested using strain P. fluorescens SBW25 containing pRL-gfp (C). Data are means of three biological replicates, and error bars represent the standard deviation of the mean. kanamycin-resistance promoter (Pk) (Heeb et al., 2000) . The DgacA mutant does not produce many of the secondary metabolites produced by wild-type Pf-5 (Hassan et al., 2010) and thus its use helps to reduce the noise in LCMS analysis. The strain DgacA (pME6010-pltM) was cultured in a medium amended with PG, and bacterial metabolites from the cultures were extracted and assayed for signal activity using SBW25 (pPL-gfp), as described for the wild-type Pf-5 above. As in the extract of wild-type Pf-5, two peaks in the extract of the DgacA (pME6010-pltM) strain, spread across six fractions (fractions 19-21, 24-26), showed signal activity ( Figure 4C ). LCMS analysis revealed compounds with protonated ions consistent with PG-Cl in fraction 21 (obs. 158.9847, calc. 158.9854, 4.4 ppm error) and 2,4-dichlorobenzene-1,3,5-triol (PG-Cl 2 ) in fraction 26 (obs. 192.9474, calc. 192.9465, 4 .7 ppm error) ( Figure 4A ). The identities of PG-Cl and PG-Cl 2 partially purified from the culture extracts were confirmed by comparing them with the synthesized authentic compounds ( Figure 4B) .
PG-Cl, a molecule with previously undescribed biological activity, has been isolated from the red alga Rhabdoina verticillata (Blackman and Matthews, 1982) . To our knowledge, PG-Cl 2 has not been previously reported. The structures of these two chlorinated phloroglucinol derivatives are consistent with the expected products of a reaction catalyzed by PltM, an FADH 2 -dependent halogenase.
PltM converts PG in vitro into chlorinated phloroglucinols that activate the expression of pltL
To determine the catalytic activity of PltM, we characterized the products generated in vitro from PG by PltM. As a putative FADH 2 -dependent halogenase, PltM is predicted to require a flavin reductase for catalysis (Nowak-Thompson et al., 1999) , but no putative flavin reductase is encoded in the plt gene cluster ( Figure 1C) . Therefore, the previously characterized NAD(P)H-dependent flavin reductase SsuE from E. coli (Keller et al., 2000) was purified and used here. The results showed that, in the presence of co-factors and flavin reductase, PltM converted PG into a compound(s) that activated pltL expression, as determined from GFP expression of SBW25 containing pRL-gfp (Figure 5) . Furthermore, LCMS analysis showed that both PG-Cl and PG-Cl 2 were present in the in vitro reaction containing PltM, but not in the reaction without PltM, based on comparisons with the authentic standards ( Figure 5-figure supplement 1) .
By evaluating a range of compounds related to PG as possible precursors, we also demonstrated that PltM exhibits a high degree of substrate specificity ( Figure 5-figure supplement 2) . These in vitro data, combined with the genetic data above, demonstrate that pltM is necessary and sufficient for converting PG into PG-Cl and PG-Cl 2 , which induce pltL expression.
Chlorinated phloroglucinols induce the PltR-mediated activation of pltL::gfp and production of pyoluteorin
We then set out to test the function of PG-Cl or PG-Cl 2 in pyoluteorin biosynthesis of Pf-5. Addition of synthesized PG-Cl or PG-Cl 2 to cultures induced, in a concentration-dependent manner, expression of pltL ( Figure 6A and B) and pyoluteorin production ( Figure 6C and D) by the DpltM mutant of Pf-5. The minimum concentration of PG-Cl 2 that induced the expression of pltL or production of pyoluteorin was 0.01 mM, which is 100-fold less than that observed for PG-Cl. These results suggest that PG-Cl 2 is a more potent signaling compound than PG-Cl. Additionally, there is evidence of toxicity: above 0.1 mM PG-Cl 2 , growth of P. protegens Pf-5 decreased ( Figure 6B ). PG-Cl was also toxic to Pf-5, but only at concentrations of 10 mM or higher. Similarly, PG-Cl and PG-Cl 2 showed inhibitory effects on the growth of P. fluorescens strain SBW25 (Figure 6-figure supplement 1) . Induction of pltL expression and pyoluteorin production by both PG-Cl and PG-Cl 2 required pltR ( Figure 6-figure supplements 2 and 3) . This is as expected because PltR is known to be the transcriptional inducer of pyoluteorin biosynthetic genes (Brodhagen et al., 2004; Li et al., 2012) . PG-Cl and PG-Cl 2 induced pyoluteorin production concurrently with decreased monoacetylphloroglucinol (MAPG) and DAPG production by the DpltM mutant ( Figure 6C and D) . This result is consistent with the known co-regulation between the pyoluteorin and DAPG biosynthetic pathways (Brodhagen et al., 2004) .
PG-Cl and PG-Cl 2 function in cell-cell communication and influence antibiosis of Pf-5 DAPG and pyoluteorin are known signals produced by distinct biosynthetic pathways with described roles in intercellular communication of P. protegens Brodhagen et al., 2004) . Several observations suggested that PG-Cl and PG-Cl 2 also function as cell-cell communication signals: (1) they are released by the bacterial cell (Figure 3 and Figure 4) ; (2) they can be taken up by the bacterial cell ( Figure 6) ; (3) they regulate gene expression at the transcriptional level and affect the output (antibiotic production) of the cell ( Figure 6) ; (4) their production varies with the growth stage of the bacterial cultures (Figure 7-figure supplement 1) ; and (5) their regulatory activities rely on a transcriptional regulator, PltR ( Figure 6-figure supplements 2 and 3) . These results, combined with our previous finding that PG can function as a chemical messenger between cells of P. protegens (Clifford et al., 2016) , collectively support the model depicted in Figure 7A , in which PG-Cl and PG-Cl 2 can be synthesized from PG by bacterial cells, released into the environment and taken up by neighboring cells to induce expression of pyoluteorin biosynthetic genes and produce pyoluteorin.
We used DphlADpltM and DphlADphlDDpltA mutants of Pf-5 to test the model. Both mutants expressed the pyoluteorin biosynthetic gene pltL at low levels as indicated by low GFP expression from pL-gfp (Table 1, Figure 7B ). The DphlADpltM mutant can produce PG but cannot convert it into PG-Cl or PG-Cl 2 , because of the deletion of pltM. Adding PG-Cl or PG-Cl 2 to the DphlADpltM mutant culture led to induced expression of pltL ( Table 1 ), indicating that this mutant could respond to the signals. The DphlADphlDDpltA mutant could not produce PG because of the deletion of phlD, but still has the capability to convert PG into PG-Cl and PG-Cl 2 : adding PG to the culture led to increased expression of pltL ( Table 1) . Neither mutant could produce pyoluteorin when grown in pure culture, because of the phlD and pltA mutations in the DphlADphlDDpltA mutant and the pltM mutation in the DphlADpltM mutant. In contrast, pyoluteorin was produced when the two mutants were grown in co-culture (Table 1) . Consistently, both mutants showed increased expression of pltL in the co-culture compared with the mutants grown in pure culture (Table 1, Figure 7B ). These results support our model ( Figure 7A ) that PG produced by the DphlADpltM mutant could be converted into PG-Cl and PG-Cl 2 by co-cultured cells of the DphlADphlDDpltA mutant; PG-Cl and PGCl 2 could then be used by the DphlADpltM mutant to induce production of pyoluteorin. As expected, the co-culture, but not the pure cultures, of the two mutants inhibited the growth of E. amylovora ( Figure 7C) , a plant pathogenic bacterium that is sensitive to pyoluteorin (Figure 7-figure supplement 2A) . It is worthy to note that neither mutant produces DAPG (Table 1 ) because of the deletion of phlA, a structural gene required for DAPG biosynthesis ( Figure 1A and B) , so DAPG production did not obscure the influence of pyoluteorin production on antibiosis.
Collectively, our results support the hypothesis that PG-Cl and PG-Cl 2 function in cell-cell communication of P. protegens and verify that cells of this bacterium can detect and respond to the chlorinated phloroglucinols produced by neighboring bacterial cells.
Discussion
The primary contribution of this work was the discovery of a novel mechanism of co-regulation between secondary metabolite biosynthetic pathways (Figure 8 ). This co-regulatory mechanism involves a metabolic intermediate that is transformed through enzymatic activity into a signal regulating gene expression. In contrast to previously described co-regulatory mechanisms involving a (Vingadassalon et al., 2015; Cano-Prieto et al., 2015) , the metabolic intermediate responsible for coordination of DAPG and pyoluteorin production is not shared by the two biosynthetic pathways. Instead, PG is an intermediate in DAPG biosynthesis and a precursor for formation of signaling molecules that activate expression of pyoluteorin biosynthetic genes (Figure 8) .
The role of antibiotics in cell-cell signaling is now widely recognized (Yim et al., 2007) , but the results of this study show that intermediates of antibiotic biosynthesis pathways can also function as, or be converted to, signaling molecules. DAPG and pyoluteorin are known to function as intra-and inter-cellular signals (Brodhagen et al., 2004; Maurhofer et al., 2004; Powers et al., 2015) . Here we found that the chlorinated phloroglucinols PG-Cl and PG-Cl 2 function as intra-and inter-cellular signaling compounds. When added to the culture medium, these compounds can induce expression of pyoluteorin biosynthetic genes in P. protegens Pf-5 (Figure 6, Figure 6-figure supplement 2) . By co-culturing mutants of Pf-5 with deficiencies in phlD and pltM, we also showed that PG, PG-Cl and PG-Cl 2 could be released from the producing cells and used by neighboring cells to induce the production of pyoluteorin (Table 1, Figure 7 ). These results support and extend those from a previous report showing that PG can serve as an intra-and inter-cellular chemical messenger, influencing the expression of pyoluteorin biosynthetic genes as well as hundreds of other genes with diverse functions in P. protegens Pf-5 (Clifford et al., 2016) . Therefore, it appears that the final products DAPG and pyoluteorin, the biosynthetic intermediate PG, and its derivatives PG-Cl and PG-Cl 2 all serve as signals influencing gene expression, the production of antibiotics, and the antimicrobial activity of P. protegens (Figure 8) . The signaling roles of small molecules released as intermediates, derivatives, or end products of antibiotic biosynthesis pathways are likely to be more consequential than previously recognized.
Activation of pyoluteorin biosynthetic genes requires PltR (Brodhagen et al., 2004; Li et al., 2012) (Figure 1) , the pyoluteorin pathway-specific positive regulator belonging to the LysR family. LysR regulators typically require a signal for activity, and the signal is commonly an intermediate or product of the regulated gene cluster (Maddocks and Oyston, 2008) . Pyoluteorin has been proposed to be the signal of PltR . However, our data indicate that the signaling effect of pyoluteorin relies on the presence of PG (Figure 2) , which is converted to PG-Cl and PG-Cl 2 (Figure 3 and Figure 5-figure supplement 1) . Despite our exhaustive attempts, we were not able to purify the PltR protein to evaluate whether or not PG-Cl or PG-Cl 2 binds to PltR in vitro (data not shown). Nevertheless, based on our data that PG-Cl and PG-Cl 2 are required for induction of the pyoluteorin biosynthetic genes (Figure 6 ), and pltR is required for the signaling action of PG-Cl and PG-Cl 2 in both P. protegens Pf-5 (Figure 6-figure supplement 2) and P. fluorescens SBW25 (Figure 6-figure supplement 2) , we speculate that that PG-Cl and PG-Cl 2 , rather than pyoluteorin, are signals required for the activity of PltR.
An interesting question is why DAPG and pyoluteorin production are so intricately enmeshed? P. protegens can occupy different environments, including the soil, plant surfaces, and insects, and interact with different organisms including bacteria, fungi, protozoa, and insects (Brodhagen et al., 2004; Jousset et al., 2009; Kidarsa et al., 2013; Henkels et al., 2014; Loper et al., 2016) . Both DAPG and pyoluteorin contribute to the antagonism of P. protegens against a range of bacteria, fungi, and oomycetes (Ohmori et al., 1978; Keel et al., 1992) and both facilitate the bacterium's establishment in fungal tissues, such as basidiocarps of the button mushroom Agaricus spp. (Henkels et al., 2014) . However, the sensitivity of a specific organism to these two antibiotics can be different. For example, pyoluteorin is twenty times more toxic than DAPG to the growth of E. amylovora (Figure 7-figure supplement 2) . Furthermore, these two compounds also have distinct ecological roles. For example, DAPG but not pyoluteorin exhibits toxicity to the amoeba Acanthamoeba castellanii (Jousset and Bonkowski, 2010) . Therefore, natural situations may exist in which it could be more advantageous to produce one compound versus the other. Additionally, antibiotic biosynthesis is associated with metabolic costs. The coordinated production of pyoluteorin and DAPG may be a mechanism for the bacterium to balance metabolic cost against the benefits conferred by production of the two antibiotics. In short, metabolic co-regulation may enable bacteria to activate the production of one antibiotic to combat certain competitors or predators or to occupy specific habitats, while reducing the metabolic burden on the cell by repressing the production of a second compound.
In summary, this study demonstrated that PG, an intermediate in the DAPG biosynthetic pathway, is converted into PG-Cl and PG-Cl 2 , which serve as signals activating expression of pyoluteorin biosynthetic genes. We also showed that PG-Cl and PG-Cl 2 can be released from and sensed by bacteria to regulate antibiosis against a bacterial pathogen, indicating that these metabolites function as cell-cell communication signals. Many questions remain related to the co-regulation of the DAPG and pyoluteorin biosynthesis pathways. Membrane receptors recognizing the various signaling compounds (DAPG, pyoluteorin, PG, PG-Cl and PG-Cl 2 ) have not been identified, but are likely needed to facilitate uptake of these molecules across the bacterial membrane. PG-Cl and PG-Cl 2 are now known to be responsible for the previously described activation of the pyoluteorin biosynthesis by nanomolar concentrations of PG, but these compounds do not appear to mediate the repression of pyoluteorin production by higher (micromolar) concentrations of PG (Kidarsa et al., 2011) . The mechanism(s) involved in inhibition of pyoluteorin production by PG remain unknown. Here, we report a novel mechanism of co-regulation that is responsible for only one aspect of the complex and intricate co-regulation of two secondary metabolites in P. protegens. Our results highlight the diversity of mechanisms involved in metabolic co-regulation in bacteria and provide an unprecedented example of co-regulation between separate biosynthetic pathways in which the intermediate of one pathway functions as a precursor of the signal(s) activating the biosynthesis of a second pathway.
Materials and methods
Strains, plasmids, primers, culture conditions and chemical compounds
The bacterial strains and plasmids used in this study are listed in Table 2 . The sequences of oligonucleotides used in this study are listed in Table 3 .
P. protegens Pf-5 and derivatives, P. fluorescens SBW25, and Erwinia amylovora were cultured at 27˚C on King's Medium B agar, Nutrient Agar (Becton, Dickinson and Company, Sparks, MD) supplemented with 1% glycerol (NAGly) or Nutrient Broth (Becton, Dickenson and Company) supplemented with 1% glycerol (NBGly). Liquid cultures were grown with shaking at 200 r.p.m. Table 1 . Concentrations of DAPG, pyoluteorin, and expression of pltL::gfp in pure cultures and co-culture of the DphlADpltM mutant and the DphlADphlDDpltA mutant of P. protegens Pf-5. PG was purchased from Sigma-Aldrich (St. Louis, MO, USA), MAPG was purchased from Sigma Aldrich Chemie GmbH (Schnelldorf, Germany), and DAPG was purchased from Toronto Research Chemicals (North York, Canada). Chlorinated phloroglucinols PG-Cl, PG-Cl 2 and PG-Cl 3 were purchased from Synthon-Lab (St. Petersburg, Russia). All compounds were >99% pure, as determined by HPLC, and were solubilized in methanol.
Construction of Pf-5 mutants and derivative strains
The DpltADphlD mutant was made by sequentially deleting phlD and pltA genes from the chromosome of wild-type P. protegens Pf-5. To delete phlD from the chromosome of Pf-5, a phlD deletion construct made previously (Kidarsa et al., 2011) was transferred into strain E. coli S17-1 and used to delete 888 bp from the phlD gene in the chromosome of Pf-5 using a previously described protocol (Kidarsa et al., 2011) . To further delete pltA, a pltA deletion construct made previously (Henkels et al., 2014 ) was used to delete 275 bp from the pltA gene in the chromosome of Pf-5. The deletion of phlD and pltA was confirmed by PCR and subsequent DNA sequencing.
To delete pltR from the chromosome of Pf-5, two DNA fragments flanking the pltR gene were PCR amplified using the oligonucleotide pair pltR UpF-Xba/pltR UpR and pltR DnR-Xba/pltR DnF ( Table 3) . These two fragments were fused together by PCR and digested using XbaI to generate a Figure 8 . Proposed model of metabolic co-regulation between DAPG and pyoluteorin biosynthetic pathways in P. protegens. Phloroglucinol (PG) is synthesized by the type III polyketide synthase PhlD in the DAPG biosynthetic pathway, and processed into PG-Cl and PG-Cl 2 by the halogenase PltM encoded in the pyoluteorin gene cluster. The PG-Cl and PG-Cl 2 putatively bind to regulator PltR and induce transcription of pyoluteorin biosynthetic genes and prompt production of pyoluteorin. In these two pathways, the final products (DAPG and pyoluteorin), the biosynthesis intermediate (PG) and its derivatives (PG-CL, PG-Cl 2 ) can be released and used by bacteria and function as cell-cell communication signals. DOI: 10.7554/eLife.22835.032 1325 bp DNA fragment containing pltR with a 925 bp internal deletion. This DNA fragment was ligated to pEX18Tc to create construct p18Tc-DpltR. This deletion construct was introduced into the DpltADphlD mutant to make the DpltADphlDDpltR triple mutant. The deletion of pltR was confirmed by PCR and subsequent DNA sequencing.
To delete pltM from the chromosome of Pf-5, two DNA fragments flanking the pltM gene were PCR amplified using the oligonucleotide pair pltMRL-F1/pltM-up-ovlp and pltM-dn-ovlp/pltRf. These two fragments were fused together by PCR and digested using EcoRI and KpnI to generate a 1120 bp DNA fragment containing pltM with a 1345 bp internal deletion. This DNA fragment was ligated to pEX18Tc to create construct p18Tc-DpltM. The construct p18Tc-DpltM was transferred into strain E. coli S17-1 and used to delete 1345 bp from the pltM gene in the chromosome of Pf-5. The deletion of pltM from Pf-5 was confirmed by PCR and subsequent DNA sequencing. (Simon et al., 1983) Plasmids pEX18Tc Gene replacement vector with MCS from pUC18, sacB + Tc r (Hoang et al., 1998) p18Tc-DpltM pEX18Tc containing pltM with an internal deletion of 1345 bp This study pPROBE-NT pBBR1 containing promoterless gfp, Km r (Miller et al., 2000) pRL-gfp pPROBE-NT containing pltR as well as the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp This study pMRL-gfp pPROBE-NT containing pltM and pltR as well as the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp This study pL-gfp Called ppltL-gfp previously. Contains the intergenic region between pltR and pltL including the promoter of pltL fused with a promoterless gfp (Yan et al., 2016) pME6010 pACYC177-pVS1 shuttle vector, Tc r (Heeb et al., 2000) pME6010-pltM pME6010 containing pltM, which is expressed from the constitutive promoter Pk This study pET28a To complement the DpltM mutant, a 1661 bp DNA fragment containing pltM was PCR amplified using oligonucleotides pltM-F1 and pltM-R1. This PCR product was digested by KpnI and EcoRI and ligated downstream of the constitutively expressing promoter (Pk) of the kanamycin resistance gene in pME6010 to make the complementation construct pME6010-pltM. The plasmid pME6010-pltM was transferred into Pf-5 derivatives by bi-parental mating (Kidarsa et al., 2011) .
Construction of protein overexpression constructs
For heterologous expression in Escherichia coli, the pltM coding sequence was PCR amplified using oligonucleotides pltM 5'primer and pltM 3'primer. The PCR product was digested with NdeI and XhoI, and ligated to the expression vector pET28a(+) to create the expression construct pET28a-PltM, in which pltM was expressed with a N-terminal fused 6X His Tag. Similarly, for SsuE, the ssuE coding sequence was PCR amplified using E. coli K12 genomic DNA as a template, and oligonucleotides ssuE 5'primer and ssuE 3'primer. The PCR product was digested with NdeI and HindIII and ligated to the expression vector pET28a(+) to create the expression construct pET28a-SsuE, in which SsuE was expressed with a N-terminal fused 6X His Tag.
Construction of transcriptional reporter constructs
For reporter constructs, three variants of pltL::GFP were constructed. pL-gfp contains the promoter of pltL fused to a promoterless gfp (Yan et al., 2016) . The construct pRL-gfp includes the entire pltR coding sequence and the predicted promoter sequence of pltL. To make this construct, a 1600 bp DNA fragment was PCR amplified using oligonucleotides pltRr and gfp-plt-r1. The resultant PCR fragment was digested with HindIII and KpnI and ligated to pPROBE-NT to create the construct pRL-gfp. The construct pMRL-gfp contains pltM and pltR and the promoter region of pltL fused to a promoterless gfp. To make this construct, a 3050 bp DNA fragment was PCR amplified using pltM 3'primer3 and gfp-plt-r1. The resultant PCR fragment was digested with BamHI and KpnI and ligated to pPROBE-NT to create the construct pMRL-gfp. 
GFP quantification
Strains P. protegens Pf-5 and P. fluorescens SBW25 containing gfp-based reporter plasmids were cultured overnight in NBGly at 27˚C with shaking. The cells were washed once with fresh NBGly and used to inoculate 5 ml NBGly to an optical density of 600 nm (OD 600 ) of 0.01. Five microliters of purified compounds at various concentrations (pyoluteorin, PG, and chlorinated derivatives of PG) or extracts (described below) were added to the 5 ml cultures. The cultures were incubated for 20 hr at 27˚C with shaking. The OD 600 was measured to monitor growth of the bacteria. The green fluorescence of bacteria was monitored using a 96-well plate reader (Tecan Infinite 200Pro, Mä nnedorf, Switzerland) by measuring emission at 535 nm with an excitation at 485 nm. For each measurement, the green fluorescence value was divided by the corresponding OD 600 to determine the relative GFP level. The green fluorescence emitted by cells of wild-type strains without gfp reporter constructs was determined and used for background correction.
Protein purification and in vitro activity assay
The expression plasmids pET28a-PltM and pET28a-SsuE were transformed into E. coli BL21 (DE3). Cells were grown in LB broth, supplemented with 50 mg/ml kanamycin, at 37˚C to an OD 600 of 0.5, induced with 0.4 mM IPTG, and grown for an additional 12 hr at 20˚C. The cells were harvested and suspended in Tris-NaCl buffer (20 mM Tris pH 7.4/200 mM NaCl), and lysed by sonication. The Histagged proteins were purified using the Ni-NTA Purification System (Invitrogen) under native purification conditions. Purified PltM and SsuE were dialyzed in Tris-NaCl-Glycerol buffer [20 mM Tris pH 7.4/200 mM NaCl/10% (vol/vol) glycerol]. The protein concentrations were determined using a DC Protein Assay (Bio-Rad) and proteins were stored at À80˚C.
To test the catalytic activity of PltM, 20 ml of 56 mM PltM, 50 ml of 21 mM SsuE, 4 ml of 10 mM FAD, 10 ml of 100 mM NADPH, and 10 ml of 10 mM PG were added to 106 ml of Tris-NaCl buffer (20 mM Tris pH 7.4/200 mM NaCl). Five additional reactions were also set up, with one of the five components replaced by an equivalent volume of the Tris-NaCl buffer in each reaction. The mixtures were incubated for 3 hr at 25˚C and extracted three times with ethyl acetate. The ethyl acetate extracts were dried under vacuum at room temperature and dissolved in 200 ml methanol. A volume of 5 ml from each methanol solution was added to P. fluorescens SBW25 containing the reporter plasmid pRL-gfp to determine the signaling activity of each reaction product. For LCMS analysis, the reactions were concentrated to dryness and dissolved in 100 ml methanol and 10 ml were analyzed as described below.
Quantification of MAPG, DAPG, and pyoluteorin
Pf-5 and derivative strains were inoculated at a starting OD 600 of 0.01 in 5 ml NBGly and cultured for 24 hr. Four milliliters of the culture supernatant were extracted twice with ethyl acetate, then subsequently dried under vacuum, and suspended in methanol. The culture extracts were analyzed by high-performance liquid chromatography (HPLC) to quantify production of MAPG, DAPG, and pyoluteorin as described below.
To quantify the production of MAPG, DAPG and pyoluteorin by Pf-5 and derivatives, HPLC analyses were accomplished using an Agilent 1100 HPLC instrument, which consisted of a quaternary pump, vacuum degasser, autosampler, column thermostat (set to 30˚C), and diode array detector. Separation was achieved using a Luna C18 column (4.6 Â 150 mm, 5 mm, Phenomenex, Torrance, CA) with a flow rate of 1 ml/min where line A was water + 0.1% (vol/vol) formic acid, and line B was acetonitrile + 0.1% (vol/vol) formic acid with the following program. The column was pre-equilibrated in 90% A/10% B, and upon injection this composition was held for 2 min. The composition of the mobile phase was then changed to 0% A/100% B over 28 min using a linear gradient. This composition was held for 6 min then changed to 90% A/10% B over 2 min. The column was equilibrated in 90% A/10% B for 6 min prior to the next injection. Under these chromatographic conditions, MAPG eluted at 12.1 min, pyoluteorin eluted at 15.1 min, and DAPG eluted at 18.1 min. The HPLC was operated with and data viewed withChemStation (version B.04.03, Agilent, Santa Clara, CA). Quantification was performed by integrating the area under the curve at 300 nm and comparing with a standard curve prepared by injection of purified pyoluteorin, MAPG, and DAPG. Data were processed with GraphPad Prism (GraphPad Software, San Diego, CA).
Identification of chlorinated phloroglucinols
For LCMS analysis of crude culture extracts of the wild-type Pf-5 and the DpltM mutant, these two strains were grown for 20 hr in 500 ml NBGly at 27˚C with shaking. The supernatants of the cultures were extracted twice with ethyl acetate (250 ml). The extracts were concentrated in vacuo to dryness. The dried extracts were dissolved in 50 ml methanol and then diluted to 400 ml with water. The large amount of precipitate formed was removed by centrifugation (15,000 x g, 60 min, 10˚C), and 10 ml of the clear supernatant were analyzed by LCMS as described below.
LCMS analysis was performed using a Agilent 1260 HPLC (consisting of degasser, quaternary pump, autosampler, and diode array detector) upstream of a 6230 ESI-TOF operated in negative ionization mode with the following parameters: Mass range, 100-3200 m/z in profile mode; Gas temperature, 350˚C; Drying gas, 10 L/min; Nebulizer, 40 psig; Capillary voltage, 3500 V; Fragmentor, 100 V; Skimmer, 65 V; OCT 1 RF Vpp, 750 V; Acquisition rate, five spectra/sec; Time, 200 ms/spectrum; Transients/spectrum, 1902). The synthesized authentic compounds PG-Cl, PG-Cl 2 and PG-Cl 3 were used as standards for comparisons in the analysis. Separation was achieved with an Extend C18 column (2 Â 100 mm, 3 mm, Agilent) at a flow rate of 0.2 ml/min. The column was pre-equilibrated in 98% A/2% B, where A was water + 0.1% (vol/vol) formic acid and B was acetonitrile + 0.1% (vol/vol) formic acid. This composition was held for 1 min and then changed to 100% B over 30 min using a linear gradient. After that, the composition was held for an additional 12 min and the composition was returned to 98% A/2% B over 2 min. The column was equilibrated at 98% A/2% B for 12 min prior to injection of the next sample. The LCMS was operated with and data were viewed using MassHunter (version B.04.03, Agilent, Santa Clara, CA).
Culture extracts from the wild-type Pf-5 were also fractioned by semi-preparatory HPLC and signal activity of the fractions was tested by the reporter strain P. fluorescens SBW25 containing pRLgfp. The wild-type Pf-5 was cultured for 20 hr in 500 ml NBGly at 27˚C with shaking before being extracted twice with ethyl acetate (250 ml). The dried extracts were dissolved in 1 ml methanol and mixed with 1 ml water. The concentrated extracts were separated by semi-preparatory HPLC using a PuriFlash Pf450 (Interchim Inc., Los Angeles, CA). Separation was achieved using a Purisphere C18 column (10 Â 150 mm, 10 mm, Interchim Inc.) at a flow rate of 2 ml/min. The column was pre-equilibrated in 90% A/10% B, where A was water and B was methanol. This composition was held for 2 min and then increased to 100% B over 40 min using a linear gradient and pure methanol was flown over the column for an additional 9 min. The effluent from the pump was collected directly into a 96-deep well plate in 1 min time slices after discarding the first 3 min to waste. Five microliters from each well were tested using SBW25 (pRL-gfp) and fluorescence was observed as described above.
To obtain sufficient levels of signaling molecules for LCMS analysis, the DgacA mutant of Pf-5 containing pME6010-pltM was cultured in three flasks, each containing 1000 ml NBGly amended with 12.5 mg/ml PG. The cultures were incubated for 20 hr at 27˚C with shaking before being extracted twice with ethyl acetate (300 ml). Extracts were concentrated in vacuo to dryness. The dried extracts from the three replicate cultures were combined and dissolved in 1.5 ml methanol. A portion (200 ml) was diluted with 1.8 ml of water. The concentrated extracts were fractioned by semi-preparatory HPLC and the signal activity of the fractions were tested using SBW25 (pRL-gfp) as described above. The fractions with the highest signal activity were concentrated to dryness separately and analyzed by LCMS along with synthesized standards including PG-Cl, PG-Cl 2 and PG-Cl 3 as described above.
Antibiosis assay
Antibiosis of Pf-5 and derivatives against the plant pathogen E. amylovora was determined on NAGly. E. amylovora was cultured overnight in 5 ml NBGly at 27˚C with shaking, and 80 ml of the cultures were inoculated into 8 ml melted NAGly (45˚C), and poured over solidified NAGly in a Petri plate. This two-layer plate was air-dried with the lid open for 1 hr to solidify the agar and remove extra moisture. The DphlADpltM mutant and the DphlADphlDDpltA mutant were cultured overnight in 5 ml NBGly at 27˚C with shaking. The cells were washed once with fresh NBGly and used to make a bacterial suspension with an OD 600 of 0.05. For co-culture, cells of the two mutants were combined in a 1:1 ratio for a total OD 600 of 0.05. Two microliters of the bacterial suspensions were used to inoculate three two-layer plates and incubated for 3 d at 27˚C. The agar medium with the Pf-5 strains in the center was cut from the plate and concentrations of DAPG and pyoluteorin in the agar were quantified as follows. Bacterial cells were carefully removed from the agar using Kimwipe. The agar was weighed, sliced into small pieces and immersed for 30 min in sterilized water before extracting twice with ethyl acetate. The extracts were dried and the residue was dissolved in 20 ml methanol and analyzed by HPLC as described above.
Statistical analysis
Statistical analyses were performed by ANOVA and Tukey multiple comparison using SPSS statistics 20 (SPSS Inc., Chicago, IL). All replicates in this study were biological replicates. Sample sizes are indicated in the figure legends. All data are presented as mean ± standard derivation.
